| ²é¿´: 167 | »Ø¸´: 0 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
CZD1972³¬¼¶°æÖ÷
|
[½»Á÷]
GMPÎļþ³£¼ûËõд
|
||
|
ABPI Association of the British Pharmaceutical Industry ADR Adverse Drug Reaction AE Adverse Event AIM Active Ingredient Manufacturer ANDA Abbreviated New Drug Application ANOVA Analysis of Variance ASM: Active Substance Manufacturer ATC Anatomical Therapeutic Chemical ATX Animal Test Exemption Certificate BAN British Approved Name BIRA British Institute of Regulatory Affairs BNF British National Formulary BP British Pharmacopoeia C of A Certificate of Analysis C of S Certificate of Suitability CENTRE FOR DRUG EVALUATION (CDE) Centre for Pharmaceutical Administration (CPA) CMS Concerned Member State CMSÿ¸ö³ÉÔ±¹ú COS Certificate of Suitability CPMP Committee for Proprietary Medicinal Products CRA Clinical Research Associate CRF Case Report Form CRO Contract Research Organisation CTA Clinical Trial Application CTC Clinical Trial Certificate CTD Common Technical Document CTX Clinical Trials Exemption DDD Defined Daily Dose DGC Daily Global Comparison DIA Drug Information Association DMF Drug Master File Drug Registration Branch (DRB), Product Evaluation & Registration Division, CPA EDQM (European Directorate for the Quality of Medicines) Å·ÖÞÁªÃËÒ©Æ·ÖÊÁ¿Ö¸µ¼Î¯Ô±»á EEA Å·ÖÞ¾¼ÃµØÇø EGMA European Generics Medicine Association ELA Established Licence Application EMEA European Medicines Evaluation Agency EMEA £¨European Agency for the Evaluation of Medicinal Products£© Å·ÖÞÁªÃËÒ©Æ·ÆÀ¼Û»ú¹¹ EP European Pharmacopoeia EPAR European Public Assessment Reports ESRA European Society of Regulatory Affairs European Pharmacopoeia Commission Å·ÖÞÒ©µäίԱ»á FDA FDA Food and Drug Administration final evaluation report (FER) free sale certificates (FSCs) GCP Good Clinical Practice GCPÒ©Æ·ÁÙ´²Ñо¿¹ÜÀí¹æ·¶ GLP Good Laboratory Practice GLP Ò©Æ·ÁÙ´²Ç°°²È«ÐÔÑо¿ÖÊÁ¿¹ÜÀí¹æ·¶ GMP Good Manufacturing Practice GMP Ò©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶ GSPÒ©Æ·ÏúÊÛ¹ÜÀí¹æ·¶ Health Sciences Authority (HSA) HSA¡¯s Medicines Advisory Committee (MAC) IB Investigators Brochure ICH International Conference for Harmonisation IDMC Independent Data-Monitoring Committee IEC Independent Ethics Committee IND Investigational New Drug INN International Non-proprietary Name International Conference on Harmonisation (ICH) IPC In Process Control IRB Institutional Review Board LICENCE HOLDER MA Marketing Authorisation MAA Marketing Authorisation Application MAAÉÏÊÐÉêÇë MAH Marketing Authorisation Holder MAH ÏúÊÛÐí¿É³ÖÓÐÕß MCA Medicines Control Agency MHW Ministry of Health and Welfare (Japan) MR Mutual Recognition MRA ÃÀ¹úÓëÅ·Ã˵Ļ¥ÈÏÐÒé MRAs (Mutual Recognition Agreements) »¥ÏàÕJ×CͬÒâ MRFG Mutual Recognition Facilitation Group MRP Mutual Recognition Procedure NAS New Active Substance NCE New Chemical Entity NDA New Drug Application new chemical entities (NCEs) new drug applications (NDAs) NSAID Non Steroidal Anti Inflammatory Drug NTA Notice To Applicants OOS Out of Specification OTC Over The Counter PAGB Proprietary Association of Great Britain Ph Eur European Pharmacopoeia PIL Patient Information Leaflet PL Product Licence POM Prescription Only Medicine PRODUCT OWNER PSU Periodic Safety Updates QA Quality Assurance QC Quality Control RAJ Regulatory Affairs Journal RMS Reference Member State RMSÏ໥ÈÏ¿ÉÁíÒ»³ÉÔ±¹ú RSD Relative Standard Deviation Rx Prescription Only SAE Serious Adverse Event SMF Site Master File SOP Standard Operating Procedure SOP £¨STANDARD OPERATION PROCEDURE£© ±ê×¼ÔË×÷³ÌÐò SPC/SmPC Summary of Product Characteristics summary of product characteristics(SPC) Therapeutic Goods Administration (TGA) USP US Pharmacopoeia VMF Veterinary Master File VPC Veterinary Products Committee |
» ²ÂÄãϲ»¶
ÇóÖú¡¶ÉúÎïÀûÓöȺÍÉúÎïµÈЧÐÔÑо¿Ö¸µ¼ÔÔò¡·£¨ÊÔ ÐУ©£¬2002
ÒѾÓÐ0È˻ظ´
ÎÄÏ×ÇóÖú
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ189È˻ظ´















»Ø¸´´ËÂ¥